Biography:

Dr. Shyam Sundar is presently working as a Professor of Medicine Head, Department of Medicine at Institute of Medical Sciences Banaras Hindu University (BHU), Varanasi, India.

Dr. Shyam Sundar first to successfully conduct multidrug therapy of VL, and these regimens are also approved by WHO as the second most preferred regimen. Combination of paromomycin and miltefosine is also being used at primary health centers by the National Control Programme.

He has also done excellent work on lipid associated amphotericin B. His work with single dose liposomal amphotericin B is considered as a major breakthrough and has earned worldwide acclaim. This single dose regimen is now the most preferred according to WHO recommendations, and it is being used in the control programme in India.

He led the pivotal paromomycin trial, based on which the drug was approval by the Government of India.